Prescription Drug Search
Product Request Form
Vandetanib is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Vandetanib becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about NationDrugs.to
List of countries where we can ship Vandetanib:
- Anguilla
- Armenia
- Bahamas
- Bolivia
- Bulgaria
- Cayman Islands
- Chile
- Cook Islands
- Costa Rica
- Cyprus
- El Salvador
- Estonia
- Fiji
- Finland
- France
- Greenland
- Guadeloupe
- Guatemala
- India
- Iran
- Jamaica
- Kuwait
- Latvia
- Liechtenstein
- Moldova, Republic of
- Netherlands
- Nicaragua
- Peru
- Poland
- Russian Federation
- Saudi Arabia
- Serbia
- Sweden
- Trinidad and Tobago
- Turkey
- United Kingdom, UK
- United States, US
- Vanuatu
- Venezuela
- Vietnam
Latest news releases on Vandetanib:
Vandetanib - Wikipedia
Vandetanib (INN, trade name Caprelsa) is an anti-cancer drug that is used for the treatment of certain tumours of the thyroid gland. It acts as a kinase inhibitor of ...
Caprelsa - min.medicin.dk – information om medicin
Tabletter. 1 tablet (filmovertrukken) indeholder 100 mg eller 300 mg vandetanib. ...
Vandetanib | C22H24BrFN4O2 - PubChem - The PubChem Project
Vandetanib | C22H24BrFN4O2 | CID 3081361 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities ...
Vandetanib - FDA prescribing information, side effects and ...
Vandetanib official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.
Vandetanib - National Cancer Institute - Comprehensive ...
This page contains brief information about vandetanib and a collection of links to more information about the use of this drug, research results, and ongoing clinical ...
CAPRELSA® (vandetanib) REMS Program | Advanced Medullary ...
Information for the CAPRELSA REMS Program. CAPRELSA ® (vandetanib), a kinase inhibitor, approved by the FDA for symptomatic or progressive medullary thyroid ...
Vandetanib (ZD6474) | VEGFR inhibitor | Read Reviews ...
Vandetanib (Zactima) is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9 cells and tyrosine kinase ...
About CAPRELSA | CAPRELSA.com
Important Safety Information. Important Safety Information: CAPRELSA ® (vandetanib) Tablets can cause a change in the electrical activity of your heart called QT ...
Vandetanib: Indications, Side Effects, Warnings - Drugs.com
Easy-to-read patient leaflet for Vandetanib. Includes indications, proper use, special instructions, precautions, and possible side effects.
Caprelsa | European Medicines Agency
The active substance in Caprelsa, vandetanib, is a ‘protein tyrosine kinase inhibitor’. This means that it blocks the activity of enzymes known as tyrosine kinases.
